Your browser doesn't support javascript.
loading
Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model development.
Barber, Paul R; Mustapha, Rami; Flores-Borja, Fabian; Alfano, Giovanna; Ng, Kenrick; Weitsman, Gregory; Dolcetti, Luigi; Suwaidan, Ali Abdulnabi; Wong, Felix; Vicencio, Jose M; Galazi, Myria; Opzoomer, James W; Arnold, James N; Thavaraj, Selvam; Kordasti, Shahram; Doyle, Jana; Greenberg, Jon; Dillon, Magnus T; Harrington, Kevin J; Forster, Martin; Coolen, Anthony C C; Ng, Tony.
Afiliação
  • Barber PR; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.
  • Mustapha R; Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Flores-Borja F; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Alfano G; Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Ng K; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Weitsman G; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.
  • Dolcetti L; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Suwaidan AA; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Wong F; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Vicencio JM; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Galazi M; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.
  • Opzoomer JW; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Arnold JN; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.
  • Thavaraj S; Tumor Immunology Group, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Kordasti S; Tumor Immunology Group, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Doyle J; Centre for Clinical, Oral & Translational Science, King's College London, London, United Kingdom.
  • Greenberg J; Systems Cancer Immunology, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Dillon MT; Daiichi Sankyo Incorporated, Newark, United States.
  • Harrington KJ; Daiichi Sankyo Incorporated, Newark, United States.
  • Forster M; The Institute of Cancer Research, London, United Kingdom.
  • Coolen ACC; The Institute of Cancer Research, London, United Kingdom.
  • Ng T; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.
Elife ; 112022 12 23.
Article em En | MEDLINE | ID: mdl-36562609
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Cabeça e Pescoço Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Cabeça e Pescoço Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article